Kevin Lobo

Kevin Lobo serves as Chairman and CEO of Stryker Corporation, one of the world's largest and most respected medical technology companies. Stryker operates across two main segments: MedSurg and Neurotechnology (surgical equipment including powered instruments, surgical navigation, endoscopy, patient handling, emergency medical equipment, and neurotechnology including neurovascular devices for stroke treatment) and Orthopaedics and Spine (joint replacement implants for hips and knees, trauma fixation, spine implants, and the Mako robotic-arm assisted surgery platform). The Mako robotic surgery system has been a game-changer for Stryker: the robot assists surgeons in joint replacement procedures (hip and knee), enabling more precise bone cuts, better implant positioning, and potentially improved patient outcomes. Mako placements create a significant competitive moat — once a hospital invests in a Mako system, it preferentially uses Stryker implants, driving recurring consumable and implant revenue. Stryker has delivered remarkably consistent financial performance — targeting upper-single-digit organic revenue growth and double-digit adjusted earnings growth through a combination of internal innovation and disciplined acquisitions. The company has acquired over 20 companies in recent years to fill technology gaps and expand into adjacent markets. Key stock drivers include orthopedic procedure volumes, Mako installation base growth, neurotechnology adoption, acquisition integration, hospital capital spending, and the competitive dynamics with Zimmer Biomet, Smith & Nephew, and Medtronic.